Tue, Sep 27, 2022
A A A
Welcome mteam
RSS

Sovereign Wealth Funds Briefing - Categorized | Investment

Temasek buys 10.16% stake in Intas Pharma from ChrysCapital

Posted on 11 November 2014

Singapore’s sovereign fund Temasek has bought 10.16 per cent stake in Intas Pharmaceuticals Ltd from PE firm ChrysCapital, for an undisclosed amount by way of a secondary PE deal, as per a press release. VCCircle had first reported that Temasek has emerged as the front-runner for buying the stake for around Rs 840 crore.
In September this year, Temasek, one of the two sovereign wealth funds of Singapore, received Competition Commission of India’s (CCI) approval to buy part of the stake held by ChrysCapital in the pharma company. It had also received a nod from FIPB, the nodal body monitoring foreign investment in the country, to go ahead with the transaction………………………………………..Full Article: Source


 Article link

This post was written by:

VRS - who has written 19873 posts on Opalesque Sovereign Wealth Funds Briefing.


Contact the author

Comments are closed.

banner
banner
banner
banner
September 2022
M T W T F S S
« Nov    
 1234
567891011
12131415161718
19202122232425
2627282930